Literature DB >> 9369828

Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis.

S J Chapman1, J Owen.   

Abstract

OBJECTIVE: Our purpose was to determine whether a single postpartum dose of a cephalosporin would effectively treat women with intrapartum chorioamnionitis and decrease the length of hospitalization. STUDY
DESIGN: After vaginal delivery consenting women who had received antibiotics for chorioamnionitis were assigned to postpartum treatment with either a single 2 gm intravenous dose of cefotetan or to cefotetan 2 gm given intravenously every 12 hours for a minimum of 48 hours. Chorioamnionitis was defined as an intrapartum temperature of > or = 100.4 degrees F and maternal or fetal tachycardia, maternal leukocytosis, or uterine tenderness. Patients were discharged when they had received their assigned dosage of cefotetan, were afebrile (temperature < 100.4 degrees F) and > or = 24 hours from delivery.
RESULTS: We studied 109 women (55 single dose, 54 multiple dose) with chorioamnionitis. The two groups were similar with regard to demographic and intrapartum characteristics. The median (range) interval from delivery to discharge was 24 hours lower in the single-dose group (33 [16 to 190] vs 57 [36 to 190] hours, p = 0.0001). The incidence of failed therapy was similar (single dose: 6/55, 11%, vs multiple dose: 2/54, 3.7%, p = 0.27).
CONCLUSIONS: A single postpartum dose of cefotetan appears to be effective treatment for intrapartum chorioamnionitis after a vaginal delivery and decreases the length of hospital stay.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369828     DOI: 10.1016/s0002-9378(97)70277-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

2.  Optimizing Treatment of Intra-amniotic Infection and Early-Onset Postpartum Endometritis: Advantages of Single-Agent Therapy.

Authors:  Norma Stiglich; Meredith Alston; Simone Vanswam
Journal:  Perm J       Date:  2011

3.  Antibiotic treatment at delivery shapes the initial oral microbiome in neonates.

Authors:  Luisa F Gomez-Arango; Helen L Barrett; H David McIntyre; Leonie K Callaway; Mark Morrison; Marloes Dekker Nitert
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

4.  Risk Factors for Postpartum Maternal Infection Following Spontaneous Vaginal Delivery Complicated by Chorioamnionitis.

Authors:  Helen A Daifotis; Megan M Smith; Anna E Denoble; Sarah K Dotters-Katz
Journal:  AJP Rep       Date:  2020-05-15

5.  A first look at chorioamnionitis management practice variation among US obstetricians.

Authors:  Mara B Greenberg; Britta L Anderson; Jay Schulkin; Mary E Norton; Natali Aziz
Journal:  Infect Dis Obstet Gynecol       Date:  2012-12-23

Review 6.  Antibiotic use and misuse during pregnancy and delivery: benefits and risks.

Authors:  Begoña Martinez de Tejada
Journal:  Int J Environ Res Public Health       Date:  2014-08-07       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.